Ralliant Corporation (NYSE:RAL) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Ralliant Corporation (NYSE:RAL) have received an average rating of “Hold” from the twelve research firms that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $50.50.

A number of research analysts recently commented on the stock. Truist Financial lowered their price objective on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Royal Bank Of Canada cut their target price on Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a research report on Friday, February 6th. Oppenheimer decreased their price target on Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a research note on Friday, February 6th. Barclays lowered their price target on Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Finally, Zacks Research lowered Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th.

Ralliant Stock Performance

Shares of RAL opened at $40.78 on Friday. The firm has a market capitalization of $4.56 billion and a PE ratio of 20.81. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. The firm has a 50-day moving average price of $47.29 and a 200 day moving average price of $46.73. Ralliant has a 52-week low of $37.27 and a 52-week high of $57.02.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to the consensus estimate of $543.04 million. The business’s revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be given a $0.05 dividend. The ex-dividend date is Monday, March 9th. This represents a $0.20 annualized dividend and a yield of 0.5%. Ralliant’s payout ratio is 10.20%.

Insider Buying and Selling

In other Ralliant news, Director Kate Mitchell bought 2,350 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The shares were acquired at an average cost of $42.48 per share, for a total transaction of $99,828.00. Following the acquisition, the director directly owned 8,411 shares of the company’s stock, valued at $357,299.28. This trade represents a 38.77% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Karen M. Bick sold 2,530 shares of the stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $46.50, for a total transaction of $117,645.00. Following the sale, the senior vice president directly owned 42,652 shares of the company’s stock, valued at approximately $1,983,318. This represents a 5.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders acquired 8,145 shares of company stock worth $332,233 in the last ninety days.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Danske Bank A S bought a new position in shares of Ralliant in the fourth quarter valued at $25,000. Westfuller Advisors LLC bought a new stake in shares of Ralliant during the 3rd quarter worth $26,000. V Square Quantitative Management LLC acquired a new position in shares of Ralliant in the 4th quarter worth $26,000. Allworth Financial LP raised its position in shares of Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after purchasing an additional 293 shares during the period. Finally, Palisade Asset Management LLC purchased a new stake in shares of Ralliant during the third quarter valued at $26,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.